Polyfunctional antibiotics affecting bacterial membrane dynamics

Anti-Infective Agents in Medicinal Chemistry

Volumn 8, Issue 1, 2009, Pages 3-16

  Nelson, Mark L ^a   Grier, Mark C ^a   Barbaro, Susan E ^b   Ismail, Mohamed Y ^a  

^a Transcept Pharmaceuticals Inc   (United States)

^b RIVIER COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZITHROMYCIN; CECROPIN D; CLARITHROMYCIN; COLISTIN; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; GRAMICIDIN DERIVATIVE; IONOPHORE; LANTIBIOTIC; LASALOCID; LIPOPEPTIDE; MACROLIDE; MONENSIN; NETILMICIN; NISIN; PARDAXIN; POLYAMINE DERIVATIVE; POLYMYXIN B; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEGRIN; ROXITHROMYCIN; STREPTOMYCIN; SURFACTIN; TEICOPLANIN DERIVATIVE; TELAVANCIN; UNINDEXED DRUG; VANCOMYCIN;

ACID FAST BACTERIUM; ANIMAL DISEASE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BIOLOGICAL ACTIVITY; BIRD DISEASE; CELL MEMBRANE PERMEABILITY; DRUG EFFICACY; DRUG PROTEIN BINDING; DRUG TARGETING; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; LIPID BILAYER; MEMBRANE BINDING; MEMBRANE BIOLOGY; MEMBRANE COMPONENT; MEMBRANE STRUCTURE; NEUROTOXICITY; NONHUMAN; PHARMACOPHORE; PROTEIN SYNTHESIS INHIBITION; RESPIRATORY TRACT INFECTION; STRUCTURE ACTIVITY RELATION;

EID: 67651100935     PISSN: 18715214     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152109787047779     Document Type: Article

References (81)

1. Chia, P. S. K.; Lindoy, L. F.; Walker, G. W.; Everett, G. W. Supramolecular transport of metal amine complexes through liquid membranes by the ionophore lasalocid A. Pure Appl. Chem. 1993, 65, 521-526.
2. Nikaido, H.; Normark, S. Sensitivity of Escherichia coli to various b-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic b-lactamases: a quantitative predictive treatment. Mol. Microbiol., 1987, 1, 29-36.
3. Lindoy, L. F. Outer-sphere and inner-sphere complexation of cations by the natural ionophore lasalocid A. Coord. Chem. Rev. 1996, 148, 349-368.
4. Mercurio, E.; Pellegrini, M.; Mierke, D. F. Structure, dynamics, and topological orientation of the polyether, ionophore antibiotic monensin, in a micellar environment. Biopolymers 1997, 42, 759-769.
5. Mimouni, M.; Hebrant, M.; Dauphin, G.; Muillard, J. Monovalent cation salts of bacterial ionophore monensin in methanol. Structural aspects from NMR experiments. J. Chem. Res. Synopsis, 1996, 6, 278-279.
6. Shimohigashi, Y.; Yoshitomi, H.; Ono, S.; Sakaguchi, K.; Waki, M. Structure function studies of gramicidin S. I. Ornithine side chains are not necessary to the antimicrobial activity. Peptide Chem., 1989, 26, 313-316.
7. Kondejewski, L. H.; Farmer, S. W.; Wishart, D. S.; Kay, C. M.; Hancock, R. E. W.; Hodges, R. S. Gramicidin S is active against both gram-positive and gram-negative bacteria. J. Biol. Chem., 1996, 271, 25261.
8. Bu, X.; Wu, X.; Ng, N. L. J.; Mak, C. K.; Qin, C.; Guo, Z. Synthesis of Gramicidin S and its analogues via an on-resin macrolactamization assisted by a predisposed conformation of linear precursors. J. Org. Chem., 2003, 69, 2681.
9. Tamaki, M.; Ishii, R.;, Kikuchi, S.; Watanabe, E. Synthesis and properties of gramicidin S analogues with smaller ring size. J. Antibiotics, 2005, 58, 293-295.
10. Katsu, T.; Kobayashi, H.; Fujita, Y. Mode of action of gramicidin S on Escherichia coli membrane. Biochim. Biophys. Acta Biomem., 1986, 860, 608-619.
11. Kuzovnikova, T. A.; Fedorov, Y. I. Heavy metal cation-induced increase in gramicidin activity. Higher sensitivity of metalloresistant mutants of 0Escherichia coli B to the antibiotic. Antibiotiki i Khimioterapiya, 1990, 35, 24-27.
12. Sugar, I. P.; Blasko, K.; Gyorgyi, S.; Shchagina, L. V.; Malev, V. V.; Lev, A. A. Cooperative binding of primycin and gramicidin on erythrocyte membranes. A cation transport study. Membr. Biochem., 1989, 8, 1-10.
13. Prenner, E. J.; Lewis, R. N. A. H.; McElhaney, R. N. The interaction of the antimicrobial peptide gramicidin S with lipid bilayer model and biological membranes. Biochim. Biophys. Acta Biomembr., 1999, 1462, 201-221.
14. Xu, Y.; Tang, P.; Zubrzycki, I. Z.; Hu, J. NMR elucidation of anesthetic binding sites in transmembrane channels. Prog. Anesthetic Mech., 2000, 6, 306-311.
15. dela Vega, A. L.; Delcour, A. H. Polyamines decrease Escherichia coli outer membrane permeability. J. Bacteriol., 1996, 178, 3715-3721.
16. Samartzidou, H.; Delcour, A. H. Excretion of endogenous cadaverine leads to a decrease in porin-mediated outer membrane permeability. J. Bacteriol., 1999, 181, 791-798.
17. Diniello, G. B.; Algranati, I. D.; Goldemberg, S. H. Streptomycin bactericidal action is dependent on polyamine endogenous levels in E. coli. Cell Mol. Biol.(Paris), 1998, 44, 521-526.
18. Yasuda, K.; Ohmizo, C.; Katsu, T. Mode of action of novel polyamines increasing the permeability of bacterial outer membrane. Int. J. of Antimicrob. Agents, 2004, 24, 67-71.
19. Li, C.; Lewis, M. R.; Gilbert, A. B.; Noel, M. D.; Scoville, D. H.; Allman, G. W.; Savage, P. B. Antimicrobial activities of amine-and guanidine-functionalized cholic acid derivatives. Antimicrob. Agents Chemother., 1999, 43, 1347-1349.
20. Helander, I. M.; Latva-Kala, K.; Lounatmaa, K. Permeabilizing action of polyethyleneimine on Salmonella typhimurium involves disruption of the outer membrane and interactions with lipopolysaccharide. Microbiology, 1998, 144, 385-390.
21. Nakae, T. Multiantibiotic resistance caused by active drug extrusion in Pseudomonas aeruginosa and other Gram-negative bacteria. Microbiologia (Madrid), 1997, 13, 273-284.
22. Davis, B. D.; Chen, L.; Tai, P.C. Misread protein creates membrane channels: an essential step in the bactericidal action of aminoglycosides. Proc. Nat. Acad. Sci. USA, 1986, 83, 6164-6168.
23. Walker, S. G.; Beveridge, T. J. Amikacin disrupts the cell envelope of Pseudomonas aeruginosa ATCC 9027. Can. J. Microbiol., 1988, 34, 12-18.
24. Belyavskaya, I. V.; Gryaznova, N. S.; Subbotina, N. A.; Afonin, V. I. Influence of aminoglycosides on [14C]benzylpenicillin binding to Escherichia coli penicillin-binding proteins. Antibiotiki i Khimioterapiya, 1989, 34, 510.
25. Nouhnejad, P.; Salehian, P. Toxicity and mechanism of action of aminoglycoside antibiotics (gentamicin and amikacin) at the level of neural membranes. Asia Pacific J. Pharm., 1989, 4, 227-231.
26. Parsons, T. D.; Obaid, A. L.; Salzberg, B. M. Aminoglycoside antibiotics block voltage-dependent calcium channels in intact vertebrate nerve terminals. J. Gen. Physiol., 1992, 99, 491-504.
27. Pessione, E.; Martinetto, P.; Giunta, C.; Achino, A.; Curino, E. The use of redox compounds as potentiators of aminoglycoside sensitivity in highly resistant gram-negative bacteria. Drugs Exp. Clin. Res., 1984, 10, 303-314.
28. Mates, S. M.; Eisenberg, E. S.; Mandel, L. J.; Patel, L.; Kaback, H. R.; Miller, M. H. Membrane potential and gentamicin uptake in Staphylococcus aureus. Proc. Nat. Acad. of Sci. USA, 1982, 79, 6693-6697.
29. Butko, P.; Salamon, Z.; Tien, H. T. Adsorption of gentamicin onto a bilayer lipid membrane. Bioelectrochem. Bioenerg., 1990, 23, 153-160.
30. Hayashida, T.; Nomura, Y.; Iwamori, M.; Nagai, Y.; Kurata, T. Distribution of gentamicin in the guinea pig inner ear as determined by immunofluorescence. Archives Oto-Rhino-Laryngol., 1985, 242, 257-264.
31. Skopicki, H. A.; Zikos, D.; Sukowski, E. J.; Fisher, K. A.; Peterson, D. R. Gentamicin inhibits carrier-mediated dipeptide transport in kidney. Am. J. Phys., 1996, 270, F531-F538.
32. Wyka, M. A.; St. John, A. C. Effects of production of abnormal proteins on the rate of killing of Escherichia coli by streptomycin. Antimicrob. Agents Chemother., 1990, 34, 534-538.
33. Steenbergen, J. N.; Alder, J.; Thorne, G. M.; Tally, F. P. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. J. Antimicrob. Chemother., 2005, 55, 283-288.
34. Alborn, W. E., Jr.; Allen, N. E.; Preston, D. A. Daptomycin disrupts membrane potential in growing Staphylococcus aureus. Antimicrob. Agents Chemother., 1991, 35, 2282-2287.
35. Silverman, J. A.; Perlmutter, N. G.; Shapiro, H. M. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob. Agents Chemother., 2003, 47, 2538-2544.
36. Boaretti, M.; Canepari, P. Purification of daptomycin binding proteins (DBPs) from the membrane of Enterococcus hirae. Microbiologica, 2000, 23, 305-317.
37. Jung, D.; Rozek, A.; Okon, M.; Hancock, R. E. W. Structural Transitions as determinants of the action of the calcium-dependent antibiotic daptomycin. Chem. Biol., 2004, 11, 949-957.
38. Rotondi, K. S.; Gierasch, L. M. A well-defined amphipathic conformation for the calcium-free cyclic lipopeptide antibiotic, daptomycin, in aqueous solution. Biopolymers, 2005, 80, 374-385.
39. Kaatz, G. W.; Lundstrom, T.S.; Seo, S. M. Mechanism of daptomycin resistance in Staphylococcus aureus. Int. J. Antimicrob. Agents, 2006, 28, 280.
40. Silverman, J.A.; Mortin, L. I.; VanPraagh, A. D. G.; Tongchuan, L.; Alder, J. Inhibition of daptomycin by pulmonary surfactant: In vitro modeling and clinical impact. J. Infect. Dis., 2005, [i 191, 2149.
41. Clausell, A.; Pujol, M.; Alsina, M. A.; Cajal, Y. Influence of polymyxins on the structural dynamics of Escherichia coli lipid membranes. Talanta, 2003, 60, 225-234.
42. Wiese, A.; Munstermann, M.; Gutsmann, T.; Lindner, B.; Kawahara, K.; Zahringer, U.; Seydel, U. Molecular mechanisms of polymyxin B-membrane interactions: direct correlation between surface charge density and self-promoted transport. J. Mem. Biol., 1998, 162, 127-138.
43. Clausell, A.; Busquets, M. A.; Pujol, M.; Alsina, A.; Cajal, Y. Polymyxin B-lipid interactions in Langmuir-Blodgett monolayers of Escherichia coli lipids: A thermodynamic and atomic force microscopy study. Biopolymers, 2004, 75, 480-490.
44. Mestres, C.; Alsina, M. A.; Busquets, M. A.; Muranyi, I.; Reig, F. Interaction of colistin with lipids in liposomes and monolayers. Int. J. Pharmaceut., 1998, 160, 99-107.
45. Clausell, A.; Rabanal, F.; Garcia-Subirats, M.; Alsina, M. A.; Cajal, Y. Synthesis and membrane action of polymyxin B analogues. Luminescence, 2005, 20, 117-123.
46. Breukink, E.; de Kruijff, B. The lantibiotic nisin, a special case or not? Biochim. Biophys. Acta Biomembr., 1999, 1462, 223-234.
47. Paul, M.; van der Donk, W. A. Chemical and enzymatic synthesis of lanthionines. Mini-Rev. Organic Chem., 2005, 2, 23-37.
48. Bierbaum, G.; Brotz, H.; Sahl, H.G. Lanthionine-containing antibiotic peptides (lantibiotics): features, functions and perspectives. BIOspektrum, 1997, 3, 51-55.
49. Pag, U.; Sahl, H. G. Multiple activities in lantibiotics - models for the design of novel antibiotics? Curr. Pharm. Des., 2002, 8, 815-833.
50. Ruhr, E.; Sahl, H. G. Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles. Antimicrob. Agents Chemother., 1985, 27, 841-845.
51. Henning, S.; Metz, R.; Hammes, W. P. Studies on the mode of action of nisin. Int. J. Food Micro. Biol., 1986, 3, 121-134.
52. Bierbaum, G.; Sahl, H. G. Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase. J. Bacteriol., 1987, 169, 5452-5428.
53. Moll, G. N.; Roberts, G. C. K.; Konings, W. N.; Driessen, A. J. M. Mechanism of lantibiotic-induced pore-formation. Antonie van Leeuwenhoek, 1996, 69, 185-191.
54. Benz, R.; Jung, G.; Sahl, H. G. Mechanism of channel-formation by lantibiotics in black lipid membranes. Nisin Novel Lantibiotics, Proc. Int. Workshop Lantibiotics, 1991, 359-372.
55. Abee, T.; Gao, F. H.; Konings, W. N. The mechanism of action of the lantibiotic nisin in artificial membranes. Nisin Novel Lantibiot. Proc. Int. Workshop Lantibiot., 1991, 373-385.
56. Sahl, H. G. Pore formation in bacterial membranes by cationic lantibiotics. Nisin Novel Lantibiot. Proc. Int. Workshop Lantibiot., 1991, 337-358.
57. Williams, D. H.; Bardsley, B. The vancomycin group of antibiotics and the fight against resistant bacteria. Angewandte Chem. Inter. Ed., 1999, 38, 1173-1193.
58. Try, A. C.; Sharman, G. J.; Dancer, R. J.; Bardsley, B.; Entress, R. M. H.; Williams, D. H. Use of model cell membranes to demonstrate templated binding of vancomycin group antibiotics. J. Chem. Soc. Perkin Trans. I: Org. and Bio-Org. Chem., 1997, 2911-2917.
59. Malabarba, A.; Nicas, T.; Ciabatti, R. Glycopeptide resistance in multiple antibiotic-resistant gram-positive bacteria: a current challenge for novel semi-synthetic glycopeptide derivatives. Euro. J. Med. Chem., 1997, 32, 459-478.
60. Hong, H.J.; Hutchings, M. I.; Neu, J. M.; Wright, G. D.; Paget, M. S. B.; Buttner, M. J. Characterization of an inducible vancomycin resistance system in Streptomyces coelicolor reveals a novel gene (vanK) required for drug resistance. Mol. Microbiol., 2004, 52, 1107-1121.
61. Sharman, G. J.; Try, A. C.; Dancer, R. J.; Cho, Y. R.; Staroske, T.; Bardsley, B.; Maguire, A. J.; Cooper, M. A.; O'Brien, D. P.; Williams, D. H. Dimerization and membrane anchoring in activity of glycopeptide antibiotics against vancomycin-resistant bacteria. J. Am. Chem. Soc., 1997, 119, 12041-12047.
62. Allen, N. E.; LeTourneau, D. L.; Hobbs, J. J. N. Molecular interactions of a semisynthetic glycopeptide antibiotic with D-alanyl-Dalanine and D-alanyl-D-lactate residues. Antimicrob. Agents Chemother., 1997, 41, 66-71.
63. Printsevskaya, S. S.; Pavlov, A. Y.; Olsufyeva, E. N.; Mirchink, E. P.; Preobrazhenskaya, M. N. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics. J. Med. Chem., 2003, 46, 1204-1209.
64. Sorbera, L. A.; Castaner, J. Telavancin hydrochloride. Drugs Future, 2004, 29, 1211-1219.
65. Goldstein, E. J. C.; Citron, D. M.; Merriam, C. V.; Warren, Y. A.; Tyrrell, K. L.; Fernandez, H. T. In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic Gram-positive species and Corynebacterium spp. Antimicrob. Agents Chemother., 2004, 48, 2149-2152.
66. Habaki, H., Isobe, S., Egashirea, R., Kawasaki, J. Permeation and concentration of erythromycin by supported and emulsion liquid membranes. J. Chem. Eng., 1998, 31, 47.
67. Imamura, Y.; Higashiyama, Y.; Tomono, K.; Izumikawa, K.; Yanagihara, K.; Ohno, H.; Miyazaki, Y.; Hirakata, Y.; Mizuta, Y.; Kadota, J.I.; Iglewski, B. H.; Kohno, S. Azithromycin exhibits bactericidal effects on Pseudomonas aeruginosa through interaction with the outer membrane. Antimicrob. Agents Chemother., 2005, 49, 1377-1380.
68. Muto, Y.; Bandoh, K.; Katoh, N.; Watanabe, K.; Ueno, K. The effect of rokitamycin on the potassium permeability of liposomes. Kenkiseikin Kansensho Kenkyu, 1989, 19, 105-112.
69. Kurato, T.; Nishimura, Y.; Tsuji, M.; Uchida, E.; Kobayashi, S.; Oguchi, K.; Hosoyamada, A.; Yasuhara, H. The effect of rokitamycin on the potassium permeability of liposomes. Showa Univ. J. Med. Sci., 1992, 4, 27.
70. Huang, H. W.; He, K.; Heller, W.; Ludtke, S. J. Interaction of lipid bilayer membranes with amphiphilic helical peptides. Proc. Rencontre de Moriond, 1995, 30th, 339-344.
71. Yeaman, M. R.; Yount, N. Y. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev., 2003, 55, 27-55.
72. Andreu, D.; Rivas, L. Animal antimicrobial peptides: an overview. Biopolymers, 1999, 47, 415.
73. Oren, Z.; Shai, Y. A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus. Eur. J. Biochem., 1996, 237, 303-310.
74. Vollenbroich, D; Pauli, G.;Oezel, M.;Vater, J. Antimycoplasma properties and application in cell culture of surfactin, a lipopeptide antibiotic from Bacillus subtilin. Appl. Envir. Microbiol., 1997, 63, 44-49.
75. Zanetti, M.; Litteri, L.; Gennaro, R.; Horstmann H.;Romeo, D. Bacternecins, defense polypeptides of bovine neutrophils, are generated from precursor molecules stored in large storage granules. J. Cell Biol., 1990, 111, 1363-1371.
76. Spitznagel, J.K. Antibiotic proteins of human neutrophils. J. Clin. Investig., 1990, 86, 1381-1386.
77. Salzet, M. Antimicrobial peptides are signalling molecules. Trends Immunol., 2002, 23, 283-284.
78. Diamond, G.; Legarda, D.; Ryan, L.K. The innate immune response of the respiratory epithelium. Immunol. Rev., 2000, 173, 27-38.
79. Risso, A. Leukocyte antimicrobial peptides: multifunctional effector molecules of innate immunity. J. Leukocyte Biol., 2000, 68, 785-792.
80. Kato, A.; Nakaya, S.; Kokubo, A.; Aiba, Y.; Ohashi, Y; Hirata, H.; Fujii, K.; Harada, K. A new anti-MRSA antibiotic complex, WAP-8294A. I. Taxonomy, isolation and biological activities. J. Antibiot., 1998, 51, 929-935.
81. Elsbach, P.; Weiss, J. Role of the bactericidal/permeability-increasing protein in host defence. Curr. Opin. Immunol., 1998, 10, 45-49.